Drug therapy of hypercalcemia due to malignancy.
Raue
F
F
Department of Internal Medicine I-Endocrinology and Metabolism, University of Heidelberg, Germany.
Pecherstorfer
M
M
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002116:Calcitonin / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D005440:Fluid Therapy; D005708:Gallium / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy* / Q000209:etiology; D009369:Neoplasms / Q000150:complications; D010257:Paraneoplastic Syndromes / Q000188:drug therapy*; D008926:Plicamycin / Q000627:therapeutic use
D000970:Antineoplastic Agents; D004164:Diphosphonates; D004232:Diuretics; D005938:Glucocorticoids; D002116:Calcitonin; D005708:Gallium; D008926:Plicamycin; C027235:gallium nitrate